phase readout
saveNCT07095712: Personalized Antisense Oligonucleotide Therapy for A Single Participant With TARDBP ALS
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: n-Lorem Foundation. Phase: PHASE1. Conditions: Amyotrophic Lateral Sclerosis
view source ↗
comments(0)
5-min edit window · permanent after that